|
|
|
|
|
|
by unishark
2008 days ago
|
|
|
> R&D spending? Guess which healthcare companies spend the most on R&D? It's not the American ones. It's all the European ones. #1 is Switzerland's Roche. #4 is Switzerland's Novartis. #6 is France's Sanofi. #9 is the UK's AstraZeneca. #10 is the UK's GlaxoSmithKlein. [1] This is yet another failed talking point. Roche has over 8000 employees in the US. https://www.roche.com/careers/our-locations/americas/usa.htm A handful of giant international companies who obviously make a big fraction of their money in the US market (selling at higher prices due to the lack of price fixing) do not provide a useful metric. Try overall stats, such as here: https://efpia.eu/publications/data-center/the-pharma-industr... And that'd just pharmaceuticals. The US has far greater dominance over other areas of biotech. But you're right, I do need to move on. This immature flaming behavior is why I avoid toxic places like reddit. |
|
|
1. That's in "millions of national currency units" (except in Japan which is in "hundred millions of national currency units") so the Japan bar is in 100M JPY, the Europe bar is in 1M EUR, and the US bar is in 1M USD. It was clearly not meant for comparison against regions, just over time.
2. Not only is the currency inconsistent the values weren't adjusted for purchasing power parity, i.e. how far a national currency unit goes in that country relatively.
If we convert the values to USD adjust for PPP the picture changes completely. All values in USD, PPP adjusted:
2016 - USA: $52.4B
2016 - Europe: $46.16B (PPP factor 1.225, EUR:USD factor 1.11)
This is about a 13% delta, not the seemingly 53% delta represented on the chart. Also, this is limited to EFPIA member companies.